Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06059144 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Induced Hypertension in Acute PRogrESsive Perforating Artery Stroke Using Peripheral Dilute noREpinephrine

Name: Induced Hypertension in Acute PRogrESsive Perforating Artery Stroke Using Peripheral Dilute noREpinephrine — clinical trial record (NCT06059144)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PRESSURE

StatusRecruiting

PhasePhase 3

SponsorUniversity Hospital, Bordeaux

Started2024-11-28

View on ClinicalTrials.gov ↗

Amendment history

2025-01-07

Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1

Trial statusNot Yet Recruiting→Recruiting

Primary completion date2025-10-01→2027-08-28

Completion date2025-12-01→2027-11-28

Start dateestimated 2024-01-01→confirmed 2024-11-28

Study sites0→1

2023-09-22

Original filing

University Hospital, Bordeaux

458 trials monitored

See 6 trials at risk

Stroke

3,268 trials monitored

See 122 trials at risk

PRESSURE is a multicenter, prospective, randomized, open, blinded end-point assessed (PROBE) trial, that aims to evaluate the efficacy and safety of drug-induced hypertension using peripheral dilute norepinephrine, in patients with acute ischemic stroke in a perforating artery territory and experiencing early neurological deterioration.

Trial Details

NCT Number	NCT06059144
Lead Sponsor	University Hospital, Bordeaux
Conditions	Stroke, Acute, Stroke, Ischemic
Enrollment	358 participants
Start Date	2024-11-28
Primary Completion	2027-08-28 (estimated)
Study Completion	2027-11-28 (estimated)
Updated on ClinicalTrials.gov	2025-01-09